Skip to content

Trial Aiming at Assessing the Effect of Humidification on the Comfort of the Patient Receiving an Oxygen Therapy

Prospective, Randomized, Multi-center Trial Aiming at Assessing the Effect of Humidification on the Comfort of the Patient Receiving an Oxygen Therapy.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01300845
Acronym
OXYREA
Enrollment
356
Registered
2011-02-23
Start date
2011-03-31
Completion date
2014-08-31
Last updated
2014-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxygen Inhalation Therapy

Keywords

Oxygen mask, Oxygen cannula, Humidification, Oxygen therapy, Intensive Care Unit

Brief summary

In France, the most used humidifying system during oxygen therapy is a non heated device with weak efficiency and non-proven clinical benefits. This study aims to assess the lack of benefits of non-heated humidification compared to no humidification, as regards to the comfort of the patient receiving oxygen therapy.

Interventions

From randomization, oxygen therapy is humidified

oxygen therapy is never humidified

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admission in Intensive Care Unit * Oxygen therapy started for less than two hours in ICU

Exclusion criteria

* Age under 18 * Pregnancy * Participation in other trials with the same endpoints * absence of registration in french health care system * patient protected by law * tracheotomised or intubated patient * Patient with non invasive ventilation * Oxygen therapy started for more than two hours in ICU * moribund

Design outcomes

Primary

MeasureTime frameDescription
A score of comfort assessed with a detailed and specific questionnaireThis score is assessed between the sixth and the eighth hour after randomizationThis score is built from answers brought in a questionnaire including 15 items. Each item can be rated from 0 to 10, allowing to increment a score on 150 points.

Secondary

MeasureTime frame
Observance level for oxygen therapyHour 6-8
Percentage of patients requiring a fibroscopic aspirations during their stay in intensive care unit or USC within the limits of 28 days.Department discharge limited by day 28
Percentage of patients requiring an intubation during their stay in intensive care unit or USC within the limits of 28 days.Department discharge limited by day 28
The specific scores of comfort for each itemsHour 6-8
The patients who had a lesion of corneas during their stay in intensive care unit or USC within the limits of 28 daysDepartment discharge limited by day 28
The length of stay in intensive care unit or USCDepartment discharge limited by day 28
mortality in intensive care unit or USC during ongoing stay within the limits of 28 days.Department discharge limited by day 28
Percentage of patients who had an ear, nose and throat infections during their stay in intensive care unit or USC within the limits of 28 days.Department discharge limited by day 28

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026